SHANGHAI–(BUSINESS WIRE)–Pacific Prime, a global health insurance intermediary group in international health insurance and employee benefits solutions, is proud to announce that two children with heart disease, financially assisted by Pacific Prime Group’s Shanghai office in China, successfully underwent surgeries in May 2025! The two children are a 3-year-old girl from Guizhou and an 11-year-old … [Read more…]

GENT, Belgium & MALVERN, Pa. & TOKYO–(BUSINESS WIRE)–#IVD–H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G sTREM2 assay for the fully automated LUMIPULSE® G immunoassay analyzers. This CLEIA (chemiluminescent enzyme immunoassay) assay is available for Research Use Only (RUO) and allows for the quantitative measurement of soluble … [Read more…]

NUBEQA® is the first and only androgen receptor inhibitor (ARi) approved by the U.S. Food and Drug Administration (FDA) as a treatment for patients with metastatic castration-sensitive prostate cancer (mCSPC) with or without chemotherapy. Approval is based on positive results from the pivotal Phase III ARANOTE trial, which demonstrated NUBEQA plus androgen deprivation therapy (ADT) … [Read more…]

FREMONT, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced the presentation of new results from the CALLA phase 3 study showing for the first time its ultrasensitive NeXT Personal circulating tumor DNA (ctDNA) blood test detected cervical cancer progression, up to 16 months ahead of imaging. The results demonstrate … [Read more…]

Launching with multiple senior living and remote monitoring home care providers LOS ANGELES–(BUSINESS WIRE)–#AI–Cairns Health, a trailblazing healthcare technology company focused on radar-driven, AI-enabled monitoring and engagement solutions, is pleased to announce the commercial launch of Luna, the company’s patented intelligent ambient sensing and voice-based digital care companion, into multiple senior living communities and home … [Read more…]

Quantoom’s customers can now access TriLink’s CleanCap mRNA capping technology; Agreement supports future expansion of essential therapeutics & vaccines in developing countries & regions SAN DIEGO–(BUSINESS WIRE)–TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has signed a non-exclusive License and Supply Agreement with Quantoom Biosciences, … [Read more…]

Patients with advanced heart failure will be treated with FlowMaker®, an innovative, fully implantable device for restoring cardiac output. BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A., a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, announces that it has received authorization from the French National Agency for the Safety of Medicines and Health … [Read more…]

European Investment Bank and Leyden Labs sign €20 million financing to advance Leyden Labs’ pandemic preparedness activities, guaranteed by European Commission’s InvestEU initiative through its Health Emergency Preparedness and Response (HERA). Funding is part of “HERA Invest,” a €110 million top-up to the European Union’s InvestEU initiative, meant to address pandemic readiness, biodefense and antimicrobial … [Read more…]

Building on U.S. success, Calm Health launches internationally to help bridge care gaps, increase engagement with employer and health benefits, and scale access to mental health resources. PALO ALTO, Calif.–(BUSINESS WIRE)–Calm, a leading mental health company, today announced the international expansion of Calm Health, its evidence-based app that provides consumers access to mental health support … [Read more…]

TOKYO–(BUSINESS WIRE)–Reinsurance Group of America, Incorporated (NYSE: RGA), a leading global life and health reinsurer, today announced that it reached an agreement with The Dai-ichi Life Insurance Company, Limited (Dai-ichi) for an RGA subsidiary to reinsure 150 billion JPY of statutory reserves through coinsurance. “Building on our successful collaboration with Dai-ichi since 2020, we are … [Read more…]